Amicus Therapeutics, Inc.

LSE:0HF9.LHealthcare

——At close · Market cap —

Amicus Therapeutics, Inc. · Valuation · TradingHolo

Shown only where the company is comparable with its peers

Multiple	Now	Sector median
P/E	−194.4×	−0.3×
Price / Book	19.2×	2.5×
Price / Sales	8.3×	3.5×
Price / Free cash flow	176.6×	3.7×
EV / EBITDA	132.0×	6.7×
Earnings yield	−0.5%	−0.8%
Free cash flow yield	0.6%	0.6%

Price at the report date ÷ trailing twelve-month earnings

No comparable valuation history is available.

Same market and sector · market cap in USD

Company	Price	Change	Mkt cap (USD)	P/E	ROE	1Y
LSE:0QCV.LAbbVie Inc. · 🌐 LSE	—	—	—	111.2×	−129.2%	—
LSE:0QAH.LMerck & Co., Inc. · 🌐 LSE	—	—	—	20.5×	34.7%	—
LSE:0QQ6.LRoche Holding AG · 🌐 LSE	—	—	—	23.2×	38.1%	—
LSE:AZN.LAstraZeneca PLC · 🌐 LSE	£123.48	−0.79%	$260.4B	25.7×	21.0%	−0.9%
LSE:0R0H.LThermo Fisher Scientific Inc. · 🌐 LSE	—	—	—	34.0×	12.6%	—
LSE:0R2B.LDanaher Corporation · 🌐 LSE	—	—	—	41.6×	6.9%	—
LSE:0R29.LIntuitive Surgical, Inc. · 🌐 LSE	—	—	—	50.4×	16.0%	—
LSE:0QZU.LVertex Pharmaceuticals Incorporated · 🌐 LSE	—	—	—	35.5×	21.2%	—
LSE:0R1F.LBristol-Myers Squibb Company · 🌐 LSE	—	—	—	16.5×	27.3%	—
LSE:0R2S.LStryker Corporation · 🌐 LSE	—	—	—	40.6×	14.5%	—